Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
310.7 USD | -0.10% | -2.70% | +7.87% |
Jul. 02 | Alvotech Says Study on Proposed Biosimilar to Prolia, Xgeva Meets Primary Endpoints | MT |
Jun. 27 | Argus Raises Amgen's Price Target to $340 From $300 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.87% | 167B | |
+55.55% | 816B | |
+39.15% | 634B | |
-6.83% | 351B | |
+17.15% | 323B | |
+7.09% | 293B | |
+13.34% | 238B | |
+0.98% | 222B | |
+13.40% | 218B | |
-3.33% | 158B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- UBS Adjusts Price Target on Amgen to $307 From $284, Maintains Neutral Rating